Lupin rolls out Lurasidone Hydrochloride in US for bipolar depression

Lupin Limited said that it has rolled out Lurasidone Hydrochloride Tablets in the strengths of 20mg, 40mg, 60mg, 80mg, and 120mg in the US.

Lurasidone Hydrochloride Tablets is a generic version of Latuda Tablets of Sunovion Pharmaceuticals.

Latuda Tablets is a daily once drug for adults and children, from 10 to 17 years, with bipolar depression.

Based on IQVIA MAT December 2022, the estimated annual sales of Lurasidone Hydrochloride Tablets in the US would be $4.2 billion.